The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sobel, R. A.
Right arrow Articles by Colvin, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sobel, R. A.
Right arrow Articles by Colvin, R. B.

The Journal of Immunology, Vol 132, Issue 5 2393-2401, Copyright © 1984 by American Association of Immunologists


ARTICLES

The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ

RA Sobel, BW Blanchette, AK Bhan and RB Colvin

Acute experimental allergic encephalomyelitis (EAE) is a T cell- mediated, neurologic disease that is under immunogenetic control. We systematically analyzed the quantity and distribution of T cells, B cells, and macrophages in the central nervous system (CNS) of susceptible and resistant guinea (GP) with a panel of seven monoclonal antibodies by using the avidin-biotin complex (ABC) immunoperoxidase technique and alpha-naphthyl-butyrate esterase (ANBE) staining. Adult EAE-susceptible strain 13 GP immunized with isogeneic spinal cord homogenate (SC) or with myelin basic protein (MBP) developed clinical signs (paralysis, weight loss, etc.) in 2 to 3 wk. T cells were present in all CNS inflammatory foci and comprised 44% of the perivascular mononuclear cells. T cells diffusely infiltrated the neuropil away from inflammatory cell aggregates. These T cells were judged to be extravascular by the lack of an associated identifiable vessel in counter-stained sections, and by their persistence following exhaustive perfusion of the brains. In routine sections, mononuclear cells could be detected only in perivascular aggregates. IgM+ B cells comprised 9% of the perivascular infiltrates and did not diffusely infiltrate the parenchyma. ANBE+ macrophages comprised the remaining 47% of the identified perivascular cells. SC- and MBP-immunized GP showed equivalent numbers of inflammatory foci, T cells, and macrophages, but SC-immunized GP had more IgM+ cells in the meninges and choroid plexus (p less than 0.001, p less than 0.02, respectively). Virtually all cells in perivascular locations were Ia+. Ia+ mononuclear cells were also present in the neuropil. EAE-resistant strain 2 GP immunized with SC developed no clinical signs. These GP had fewer perivascular foci than strain 13 GP but, when present, the cellular composition, including the density of diffuse parenchymal T cell infiltrates, was indistinguishable. Significantly fewer parenchymal mononuclear cells in the strain 2 GP, however, displayed Ia, both in perivascular and diffuse infiltrates (p less than 0.001). We conclude that T cell migration into the CNS parenchyma is a characteristic feature of acute EAE in the GP, but that T cells can occur in this pattern without clinical signs of disease. The two features that distinguish susceptible and resistant strains were the frequency of perivascular infiltrates and the expression of Ia on parenchymal mononuclear cells, which probably reflects their enhanced immunologic activation in situ.


This article has been cited by other articles:


Home page
J. Immunol.Home page
V. Dardalhon, A. S. Schubart, J. Reddy, J. H. Meyers, L. Monney, C. A. Sabatos, R. Ahuja, K. Nguyen, G. J. Freeman, E. A. Greenfield, et al.
CD226 Is Specifically Expressed on the Surface of Th1 Cells and Regulates Their Expansion and Effector Functions
J. Immunol., August 1, 2005; 175(3): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Quintanar-Stephano, R. Chavira-Ramirez, K. Kovacs, and I. Berczi
Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats
J. Endocrinol., January 1, 2005; 184(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Reddy, Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R. A. Sobel, K. W. Wucherpfennig, and V. K. Kuchroo
Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis
PNAS, October 26, 2004; 101(43): 15434 - 15439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader
Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis
J. Immunol., August 1, 2002; 169(3): 1561 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. A. Encinas, M. B. Lees, R. A. Sobel, C. Symonowicz, H. L. Weiner, C. E. Seidman, J. G. Seidman, and V. K. Kuchroo
Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis
Int. Immunol., March 1, 2001; 13(3): 257 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Young, L. D. Lowe, S. S. Booth, M. J. Whitters, L. Nicholson, V. K. Kuchroo, and M. Collins
IL-4, IL-10, IL-13, and TGF-{beta} from an Altered Peptide Ligand-Specific Th2 Cell Clone Down-Regulate Adoptive Transfer of Experimental Autoimmune Encephalomyelitis
J. Immunol., April 1, 2000; 164(7): 3563 - 3572.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. K. Vartanian and S. de la Monte
Case 1-1999- A 53-Year-Old Man with Fever and Rapid Neurologic Deterioration
N. Engl. J. Med., January 14, 1999; 340(2): 127 - 135.
[Full Text] [PDF]


Home page
ScienceHome page
W. Hickey and H Kimura
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Science, January 15, 1988; 239(4837): 290 - 292.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.